Cleared Traditional

K031741 - MEDLEY ETCO2 MODULE (INCLUDES ACCESSORIES), MODEL 8300

K031741 is an FDA 510(k) clearance for MEDLEY ETCO2 MODULE (INCLUDES ACCESSORIES), manufactured by Alaris Medical Systems, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 250-day FDA review.

K031741 · Alaris Medical Systems, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2004
Decision
250d
Days
Class 2
Risk

K031741 is an FDA 510(k) clearance for the MEDLEY ETCO2 MODULE (INCLUDES ACCESSORIES), MODEL 8300. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Alaris Medical Systems, Inc. (San Diego, US). The FDA issued a Cleared decision on February 9, 2004 after a review of 250 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Alaris Medical Systems, Inc. devices

FDA 510(k) Submission Details - K031741

510(k) Number K031741 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2003
Decision Date February 09, 2004
Days to Decision 250 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d slower than avg
Panel avg: 140d · This submission: 250d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 192
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K031741.
SMART BITEBLOC
K042665 · Oridion Medical 1987 , Ltd. · Nov 2004
CAP-ONE, MODEL TG-920P
K040875 · Nihon Kohden America, Inc. · Oct 2004
MODIFICATION TO VAMOS ANESTHETIC GAS MONITOR
K040847 · Draeger Medical, Inc. · Jun 2004
DATEX-OHMEDA S/5 SINGLE-WIDTH AIRWAY MODULE M-MINIC AND ACCESSORIES
K023454 · Datex-Ohmeda · Apr 2003
GAS SAMPLING LINES
K023579 · Promedic, Inc. · Jan 2003
MULTIGAS UNIT, MODEL AG-920RA
K020046 · Nihon Kohden America, Inc. · Jul 2002